Publicaciones en las que colabora con Elena Perez Ceballos (9)

2013

  1. Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: A case control study

    BMC Cancer, Vol. 13

2008

  1. Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin

    Laboratory Investigation, Vol. 88, Núm. 3, pp. 306-317

2007

  1. Antithrombin Cambridge II (A384S): An underestimated genetic risk factor for venous thrombosis

    Blood, Vol. 109, Núm. 10, pp. 4258-4263

  2. Evaluation of four rapid methods for hemoglobin screening of whole blood donors in mobile collection settings

    Transfusion and Apheresis Science, Vol. 36, Núm. 3, pp. 235-242

2006

  1. A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis

    Blood, Vol. 108, Núm. 1, pp. 177-183

  2. L-asparaginase-induced antithrombin type I deficiency: Implications for conformational diseases

    American Journal of Pathology, Vol. 169, Núm. 1, pp. 142-153

2005

  1. Protein Z-dependent protease inhibitor W303X mutation in venous thrombosis [1] (multiple letters)

    British Journal of Haematology

2004

  1. Evaluation of refrigerated platelet concentrates supplemented with low doses of second messenger effectors

    Clinical and Laboratory Haematology, Vol. 26, Núm. 4, pp. 275-286

2002

  1. Prothrombin A19911G and G20210A polymorphisms' role in thrombosis

    British Journal of Haematology, Vol. 118, Núm. 2, pp. 610-614